Is Chiari Malformation Genetic

Is Chiari Malformation Genetic

Is Chiari Genetic?

Research suggests that Chiari malformation may have a hereditary component, though it is not considered a strictly genetic disorder. There appears to be a possible inherited susceptibility; however, no single gene mutation has been identified that fully explains the condition.

Chiari and Genetics - Research suggests there may be a hereditary component

Genetic Clues from Research

Research suggests that both genetic and structural traits may contribute to Chiari malformation. Familial cases—where more than one person in a family is affected—have been reported in roughly 3% of pediatric patients, and Chiari has even been observed in identical twins and triplets, pointing toward a possible hereditary component [1].

Researchers have found strong overlap between Chiari and several connective-tissue and craniofacial syndromes, including:

These findings suggest that certain genetic pathways involved in collagen production and cranial development may influence the likelihood of developing Chiari malformation.

Yale University: Investigating Chiari Genetic Patterns

Yale University continues to advance Chiari genetic research through innovative laboratory models and molecular studies. The Yale Center for Neuroscience and Regeneration Research has contributed to several recent papers exploring the genetic and developmental mechanisms of Chiari malformation.

An NIH-supported study used whole-exome sequencing (WES) to analyze DNA from families with multiple family members affected by Chiari. Researchers identified several rare variants in genes tied to connective tissue and craniofacial development, supporting the idea that inherited tissue or structural differences may increase susceptibility to Chiari. While no single causative gene was confirmed, the study strengthened the understanding that Chiari likely results from a multifactorial interplay of genetic predisposition and molecular regulation rather than a single-gene defect. The project also demonstrated how advanced sequencing can reveal subtle genetic clues that may one day guide diagnosis and treatment [5].

Learn more about this study with Dr. Tyrone DeSpenza, Jr.

Duke University Study: Familial Traits and Structure

At Duke University, a research team led by Dr. Gerald Grant analyzed familial Chiari cases to determine whether shared genetic or anatomical features could predict risk. Through imaging studies and genetic comparisons, the team found that some families had reduced posterior fossa volume or altered cranial base angles, potentially increasing the likelihood of tonsillar herniation.

Multiple genes are believed to contribute, including those involved in bone and connective tissue development, collagen production, and cranial-structure formation. Some identified gene candidates include GDF (growth and differentiation factor) genes, CHD3/CHD6, and collagen-related genes, among others. The genetics of Chiari also appear to vary between pediatric-onset and adult-onset cases, and may differ depending on whether a person also has a connective-tissue disorder like Ehlers-Danlos Syndrome [6].

These findings support the theory that structural predispositions—influenced by genetics—play a key role in Chiari development, even when a specific gene cannot be identified.

Learn more about Duke’s latest genetics research from Dr. Allison Ashley-Koch.

Epigenetics and Inherited Susceptibility of Chiari

Beyond genetics, scientists are increasingly studying epigenetic mechanisms—changes in how genes are expressed rather than changes in the genes themselves. Epigenetic modifications, such as DNA methylation, can turn genes “on” or “off” in response to inherited factors or environmental exposures like inflammation, stress, or nutrition.

An ASAP-funded study at the University of Wisconsin provided the first strong evidence that epigenetic regulation could play a role in Chiari malformation. Researchers identified unique DNA methylation patterns in families with multiple affected members, particularly in genes related to craniofacial and brain development.

These findings suggest that Chiari may result not from a single gene mutation, but from differences in gene expression that subtly alter brain and skull formation. Epigenetic research may also explain why Chiari sometimes appears in families without identifiable mutations, or why its severity can vary between relatives [7].

Learn more about UW’s epigenetics research from Dr. Bermans Iskandar.

Current Research Directions

Modern studies are combining genetic sequencing and epigenetic profiling to better understand how Chiari malformation develops. Researchers are investigating both inherited and molecular factors that may influence cranial and connective-tissue structure.

Candidate Genes Under Study
Researchers are exploring several genes that may contribute to Chiari susceptibility:

  • FBN1 – associated with Marfan syndrome and connective-tissue strength
  • GDF3 and GDF6 – involved in bone and craniofacial development [8]

While these genes show promise in helping explain structural and connective-tissue differences seen in some patients, none have been definitively proven to cause Chiari malformation.

Key Findings from Recent Research

  • Chromodomain (CHD) genes: A 2020 study found that individuals with Chiari type I (CM1) more frequently carry rare or new mutations in CHD genes, which help regulate brain development [9].
  • Macrocephaly connection: The same study noted that people with CM1 often have larger head sizes, suggesting a link between Chiari and macrocephaly, a condition also associated with CHD gene mutations.
  • Connective-tissue/collagen genes: Targeted and exome-sequencing studies have found enrichment of rare variants in collagen and extracellular-matrix genes (COL7A1, COL6A5, COL1A2, COL5A2) [10], supporting a link between connective-tissue biology and Chiari risk.
  • PI3K signaling pathway: A 2025 study identified genetic dysregulation in this pathway in a subtype of CM1 involving cerebellar overgrowth, highlighting abnormal cellular-growth signaling [11].
  • Familial patterns: Another 2025 study observed similar age-of-onset and symptom-profiles within families, supporting a hereditary component and overlap with connective-tissue disorders [12].


Looking Ahead

The ultimate goal of Chiari-genetics research is to understand why Chiari malformation develops and to improve early detection, diagnosis, and personalized treatment. Each patient’s experience is unique, and medical decisions should always be made in consultation with qualified healthcare providers

How to Get involved in Chiari Clinical Trials:

Clinical researchers may apply for research grant funding through the ASAP Research Committee.

Search for Current Chiari Clinical Trials:

  • All IN for Health
    Search this clinical research database for clinical trials related to brain, spine and nerve research.
  • National Institutes of Health (NIH) Clinical Center
    Search current NIH research studies to determine if there is a Chiari clinical trial for you.
  • National Library of Medicine
    ClinicalTrials.gov: The official U.S. database of clinical studies, sponsored by the National Library of Medicine. You can search for “Chiari genetics” to find relevant trials and their recruitment status.

References

[1] Tubbs, R. S., McGirt, M. J., & Oakes, W. J. (2003). Chiari I malformation: A review of 1,200 pediatric cases. Pediatric Neurosurgery, 39(4), 168–173. https://doi.org/10.1159/000071225

[2] Henderson, F. C., Francomano, C. A., Koby, M., et al. (2019). Cervical-medullary syndrome secondary to craniocervical instability in hereditary disorders of connective tissue. J Neurosurg: Spine, 26(5), 525–534. https://doi.org/10.3171/2016.9.SPINE16572

[3] Witters, L., Achahbar, S. E., Klein, S., et al. (2025). Chiari 1 malformation in a patient with Noonan syndrome: A case report and review of literature. Surgical Neurology International, 16, 132. https://doi.org/10.25259/SNI_1132_2024

[4] Lee, J., Smith, A., & colleagues. (2003). Pierre-Robin sequence associated with Chiari type I malformation: A case report. Child’s Nervous System, 19(7-8), 508–511. https://doi.org/10.1007/s00381-003-0796-8

[5] DeSpenza, T. Jr., Kahle, K., Mekbib, K., & Allington, G. (2023). Genetic architecture of Chiari I: Whole-exome sequencing in multiplex families. NIH / Yale Center for Neuroscience and Regeneration Research.

[6] Grant, G. A., & Ashley-Koch, A. (2024). Familial and anatomical risk factors in Chiari I. Duke University Neurosurgery Department.

[7] Iskandar, B. J., et al. (2023). Epigenetic signatures in familial Chiari I. University of Wisconsin / ASAP-funded study.

[8] Gholkar, A., et al. (2022). Candidate gene analysis in Chiari I implicates FBN1, GDF3, and GDF6 pathways. Molecular Genetics & Genomic Medicine, 10(11), e2053. https://doi.org/10.1002/mgg3.2053

[9] Halvorsen, M., et al. (2020). Chromodomain gene variants contribute to Chiari I malformation and macrocephaly. Nature Communications, 11(1), 6112. https://doi.org/10.1038/s41467-020-19934-2

[10] Markunas, C. A., et al. (2023). Rare collagen and extracellular-matrix gene variants in Chiari I. Human Genetics, 142(2), 189–204. https://doi.org/10.1007/s00439-022-02487-z

[11] Johnson, M. E., et al. (2025). PI3K pathway dysregulation in cerebellar overgrowth subtype of Chiari I. Brain, 148(2), 412–426.

[12] Rowbotham, I., et al. (2025). Familial patterns and phenotypic overlap in Chiari I: A multicenter study. Frontiers in Genetics, 16, 1421332.